Smith Alan E

Insider Reports History

Entity
Company
Location
One Kendall Square, Cambridge, MA
Signature
/s/ Alan E. Smith
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Smith Alan E:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Candel Therapeutics, Inc. Director Common Stock 32.5K $29.3K $0.90 Jul 26, 2021 Direct

Insider Reports Filed by Smith Alan E

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CADL Candel Therapeutics, Inc. Jul 26, 2021 0 $0 3 Jul 26, 2021 Director